Nektar Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Nektar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nektar Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nektar Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.7M | 22k | 76.64 |
| 2026-03-31 | $16M | 240k | 65.00 |
| 2025-09-30 | $1.1k | 19 | 57.00 |